SweetValueLab
Write for us

Samantha McLemore

Patient Capital Management, LLCCIK 0001854794Form 13F-HR on EDGAR
Portfolio value$3.1B
Positions40
QuarterQ2 2026ended 2026-06-30
Filed08/132026

Patient Capital Management, LLC's Q2 2026 13F, filed Aug 13, 2026, reports 40 positions worth $3.1B. The ten largest are 51.4% of the book, led by Royalty Pharma Plc at 6.6%, Citigroup at 6.4% and Alphabet (Class A) at 6.2%. Against Q1 2026: 2 bought, 12 added to, 24 reduced, 2 sold; the largest moves were bought Global Payments and reduced Noble Corp Plc (−93%).

Where the money is

top 10 = 51% of the portfolio

Holdings

40 positions · Q2 2026 · change vs Q1 2026
TickerIssuerWeightValueQ-end → nowPrice vs modelChange

Source: the manager's Form 13F-HR on SEC EDGAR, kept as immutable quarterly snapshots; changes compare two consecutive filings. A 13F is filed up to 45 days after quarter end and covers US-listed long positions only. Tickers come from a self-maintained CUSIP map; a position without one shows its CUSIP. Method notes in where the numbers come from.